Laurus Labs says Richcore buy will help it become a leading biotech contract manufacturer
In an interview to Moneycontrol, Satyanarayana Chava, CEO of Laurus Labs, said Richore acquisition will help them leapfrog in biotech which is considered to be capital intensive with high gestation periods for breakeven.
Latest News from Moneycontrol.com